Credit Suisse’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.04M | Hold |
115,418
| – | – | ﹤0.01% | 2239 |
|
2023
Q4 | $1.3M | Buy |
115,418
+30,733
| +36% | +$345K | ﹤0.01% | 2160 |
|
2023
Q3 | $731K | Sell |
84,685
-2,703
| -3% | -$23.3K | ﹤0.01% | 2471 |
|
2023
Q2 | $904K | Sell |
87,388
-72,555
| -45% | -$751K | ﹤0.01% | 2433 |
|
2023
Q1 | $1.74M | Buy |
159,943
+59,718
| +60% | +$648K | ﹤0.01% | 1951 |
|
2022
Q4 | $1.12M | Buy |
100,225
+28,605
| +40% | +$321K | ﹤0.01% | 2245 |
|
2022
Q3 | $727K | Buy |
71,620
+382
| +0.5% | +$3.88K | ﹤0.01% | 2540 |
|
2022
Q2 | $646K | Buy |
71,238
+5,890
| +9% | +$53.4K | ﹤0.01% | 2668 |
|
2022
Q1 | $624K | Sell |
65,348
-913
| -1% | -$8.72K | ﹤0.01% | 2827 |
|
2021
Q4 | $732K | Sell |
66,261
-3,392
| -5% | -$37.5K | ﹤0.01% | 2789 |
|
2021
Q3 | $516K | Buy |
69,653
+6,931
| +11% | +$51.3K | ﹤0.01% | 2970 |
|
2021
Q2 | $910K | Buy |
62,722
+13,888
| +28% | +$201K | ﹤0.01% | 2697 |
|
2021
Q1 | $996K | Sell |
48,834
-13,685
| -22% | -$279K | ﹤0.01% | 2581 |
|
2020
Q4 | $1.11M | Buy |
62,519
+17,534
| +39% | +$312K | ﹤0.01% | 2511 |
|
2020
Q3 | $664K | Sell |
44,985
-68,067
| -60% | -$1M | ﹤0.01% | 2515 |
|
2020
Q2 | $2.37M | Sell |
113,052
-27,673
| -20% | -$581K | ﹤0.01% | 1738 |
|
2020
Q1 | $3.25M | Sell |
140,725
-7,416
| -5% | -$171K | ﹤0.01% | 1376 |
|
2019
Q4 | $3.84M | Buy |
148,141
+60,976
| +70% | +$1.58M | ﹤0.01% | 1575 |
|
2019
Q3 | $1.7M | Buy |
87,165
+65,288
| +298% | +$1.27M | ﹤0.01% | 2045 |
|
2019
Q2 | $357K | Sell |
21,877
-21,402
| -49% | -$349K | ﹤0.01% | 2961 |
|
2019
Q1 | $981K | Buy |
43,279
+4,298
| +11% | +$97.4K | ﹤0.01% | 2383 |
|
2018
Q4 | $997K | Buy |
38,981
+5,398
| +16% | +$138K | ﹤0.01% | 2289 |
|
2018
Q3 | $1.1M | Sell |
33,583
-15,601
| -32% | -$510K | ﹤0.01% | 2351 |
|
2018
Q2 | $1.12M | Sell |
49,184
-5,665
| -10% | -$128K | ﹤0.01% | 2512 |
|
2018
Q1 | $1.33M | Buy |
54,849
+8,757
| +19% | +$212K | ﹤0.01% | 2384 |
|
2017
Q4 | $1.29M | Sell |
46,092
-13,119
| -22% | -$366K | ﹤0.01% | 2354 |
|
2017
Q3 | $2.03M | Buy |
59,211
+24,974
| +73% | +$855K | ﹤0.01% | 2128 |
|
2017
Q2 | $1.36M | Sell |
34,237
-5,009
| -13% | -$200K | ﹤0.01% | 2148 |
|
2017
Q1 | $1.45M | Sell |
39,246
-7,942
| -17% | -$292K | ﹤0.01% | 2265 |
|
2016
Q4 | $1.5M | Sell |
47,188
-69,442
| -60% | -$2.21M | ﹤0.01% | 2361 |
|
2016
Q3 | $4.23M | Sell |
116,630
-6,392
| -5% | -$232K | ﹤0.01% | 1563 |
|
2016
Q2 | $2.79M | Buy |
123,022
+19,043
| +18% | +$432K | ﹤0.01% | 1851 |
|
2016
Q1 | $1.96M | Sell |
103,979
-1,736
| -2% | -$32.6K | ﹤0.01% | 1988 |
|
2015
Q4 | $1.73M | Buy |
105,715
+4,012
| +4% | +$65.8K | ﹤0.01% | 2202 |
|
2015
Q3 | $1.12M | Sell |
101,703
-28,649
| -22% | -$315K | ﹤0.01% | 2541 |
|
2015
Q2 | $1.7M | Buy |
130,352
+14,349
| +12% | +$187K | ﹤0.01% | 2456 |
|
2015
Q1 | $2.01M | Buy |
116,003
+3,039
| +3% | +$52.7K | ﹤0.01% | 2161 |
|
2014
Q4 | $1.69M | Buy |
112,964
+19,812
| +21% | +$296K | ﹤0.01% | 2376 |
|
2014
Q3 | $2.15M | Buy |
93,152
+35,559
| +62% | +$819K | ﹤0.01% | 2110 |
|
2014
Q2 | $1.84M | Buy |
+57,593
| New | +$1.84M | ﹤0.01% | 2432 |
|